Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Finasteride use may cause sperm damage and infertility, stopping it can improve sperm health.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Minoxidil with Korean red ginseng improves hair density and thickness more than minoxidil alone.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

Teratoma hair is similar to scalp hair but has a rougher surface and lower adhesive force.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

A woman experienced temporary hair loss after jaw surgery, which can be reduced by careful head positioning during the operation.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Polycystic ovary syndrome (PCOS) significantly impacts women's emotional well-being and social lives, requiring treatments that include psychological support.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.